相关实验视频

Updated: Sep 13, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

在HER-2阳性乳腺癌的分子诊断和向治疗方法的进步

Basma Albanyahyati^1,2,3, Hicham El Hadi¹, Youssef Bakri^2,3

¹Diagnostic kit and medical devices center, Moroccan Foundation for Advanced Science Innovation and Research (MASCIR), University Mohammed VI Polytechnic, Lot 660, Hay Moulay Rachid Ben Guerir, 43150, Morocco.

Asian Pacific journal of cancer prevention : APJCP

|July 29, 2025

概括

对人类表皮生长因子受体2 (HER2) 状态的准确诊断对于有效的乳腺癌治疗至关重要. 分子诊断技术的进步改善了精准医学和向的HER2阳性乳腺癌疗法.

科学领域:

在瘤学瘤学.
分子诊断学分子诊断
精准医学是一门精准的医学.

背景情况:

人体表皮生长因子受体2 (HER2) 是一种与侵袭性乳腺癌和患者不良结果相关的生物标志物.
包括PI3K/Akt和MAPK在内的HER2信号通路对于乳腺癌的进展至关重要.
准确的HER2状态确定对于指导特斯图祖马布等向疗法至关重要.

研究的目的:

对乳腺癌中HER2状态的分子诊断技术的进步进行审查.
讨论针对性治疗在治疗HER2阳性乳腺癌中的作用.
突出新诊断方法与精准医学方法的整合.

主要方法:

传统诊断方法的审查:免疫组织化学 (IHC) 和光现场混合 (FISH).
评估先进的分子诊断技术,特别是定量实时逆转录PCR (RT-qPCR).
对针对HER2阳性乳腺癌的向治疗方法的临床试验数据的分析.

主要成果:

像RT-qPCR这样的分子诊断技术补充了HER2状态诊断的传统方法.
诊断方面的进步使得 HER2 阳性乳腺癌的个性化治疗策略成为可能.
向疗法,包括抗体,抗体药物合物 (ADC) 和氨酸激酶抑制剂,在HER2阳性病例中是有效的.

结论:

改进的分子诊断对于 HER2 阳性乳腺癌的精准医学至关重要.
向疗法和新兴免疫疗法提供了改进的管理选择.
持续的研究和临床试验对于优化乳腺癌治疗结果至关重要.

关键词:

HER2 (或ErbB2) 的发生.精准医学是一门精准的医学.乳腺癌乳腺癌乳腺癌分子诊断分子诊断分子诊断

更多相关视频

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...